Globus Medical (GMED) EBITDA Margin (2011 - 2026)
Globus Medical's EBITDA Margin was 31.91% in Q2 2026, up 12.22 percentage points from 19.69% a year earlier and up 2.92 percentage points from the prior quarter.
Globus Medical (GMED) EBITDA Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Globus Medical's EBITDA Margin was 29.24% through Jun 30, 2026, up 8.21 percentage points year-over-year; for FY2025, it was 25.75%, up 9.10 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +3.66 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 16.65% in FY2024 (-1.12 pp), 17.77% in FY2023 (-11.19 pp), 28.96% in FY2022 (+3.72 pp) and 25.24% in FY2021 (+3.15 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2022.
- Compared with a year earlier, EBITDA Margin has increased for eight straight quarters, with an average year-over-year change of +8.17 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q1 2025 (a gain of 16.77 percentage points); the worst was Q3 2023 (a drop of 20.56 percentage points).
- Per Business Quant data, GMED's EBITDA Margin in the three quarters before Q2 2026 was 28.99% (Q1 2026), 28.84% (Q4 2025) and 27.16% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 9.79% |
| 10 | Globus Medical | 9.97 Bn | 7.67 Bn | 530.80 Mn | 32.46% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 32.46% |
| Jun 30, 2026 | 31.91% |
| Mar 31, 2026 | 28.99% |
| Dec 31, 2025 | 28.90% |
| Sep 30, 2025 | 27.10% |
| Jun 30, 2025 | 19.69% |
| Mar 31, 2025 | 27.19% |
| Dec 31, 2024 | 19.45% |
| Sep 30, 2024 | 18.39% |
| Jun 30, 2024 | 17.98% |
| Mar 31, 2024 | 10.43% |
| Dec 31, 2023 | 13.31% |
| Sep 30, 2023 | 9.84% |
| Jun 30, 2023 | 29.01% |
| Mar 31, 2023 | 27.10% |
| Dec 31, 2022 | 26.19% |
| Sep 30, 2022 | 30.89% |
| Jun 30, 2022 | 32.70% |
| Mar 31, 2022 | 28.18% |
| Dec 31, 2021 | 14.42% |
Globus Medical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GMED&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "GMED", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GMED&period=max&api_key=YOUR_API_KEY");
const data = await res.json();